Polymicrobial methicillin-resistant Staphylococcus aureus bloodstream infections
Open Access
- 5 November 2024
- journal article
- research article
- Published by American Society for Microbiology in Microbiology Spectrum
- Vol. 12 (11) , e0108124
Abstract
Methicillin-resistant Staphylococcus aureus (MRSA) bloodstream infection (BSI) is a serious public health concern. At times, MRSA is isolated from the blood along with other pathogens, the significance and consequences of which are not well described. This study aims to outline the clinical characteristics and outcomes of those with polymicrobial MRSA BSI compared with those with monomicrobial MRSA BSI. We conducted a retrospective case-control study of those with and without polymicrobial MRSA BSI from 2014 to 2022 at a single quaternary care center in New York City. Risk factors and outcomes for polymicrobial MRSA BSI were assessed using logistic regression analyses. Of 559 patients with MRSA BSI during the study period, 49 (9%) had polymicrobial MRSA BSI. Gram-positive Enterococcus (23%) was the most common co-pathogen. The presence of urinary ( P = 0.02) and gastrointestinal ( P < 0.01) devices was significantly associated with polymicrobial MRSA BSI. Polymicrobial MRSA BSI was associated with intensive care unit (ICU) admission after BSI ( P = 0.01). Mortality did not differ. While polymicrobial MRSA BSI is relatively uncommon, it complicates an already complex clinical scenario of MRSA BSI. IMPORTANCE: Staphylococcus aureus is a common human pathogen associated with severe disease and high mortality rates. Although clinically observed, little is known about the impact of polymicrobial staphylococcal bloodstream infection. This study evaluates polymicrobial methicillin-resistant S. aureus bloodstream infection (BSI), highlighting the increased risk of intensive care unit admission and impact on morbidity. Identifying risk factors for polymicrobial BSI, such as the presence of specific devices, can aid in early recognition and targeted interventions. Clarifying the risks and outcomes of polymicrobial infections can lead to strategies to minimize and manage these infections and explore the potential interactions between pathogens.Keywords
Funding Information
- HHS | NIH | National Center for Advancing Translational Sciences (KL2TR001435)
- HHS | NIH | National Institute of Allergy and Infectious Diseases (AI119145)
- New York State Department of Health (Empire Clinical Research Investigator Program)
This publication has 15 references indexed in Scilit:
- Blurred Molecular Epidemiological Lines Between the Two Dominant Methicillin-Resistant Staphylococcus aureus ClonesOpen Forum Infectious Diseases, 2019
- Polymicrobial bloodstream infections: Epidemiology and impact on mortalityJournal of Global Antimicrobial Resistance, 2013
- Polymicrobial Interactions: Impact on Pathogenesis and Human DiseaseClinical Microbiology Reviews, 2012
- Dissemination of an Enterococcus Inc18-Like vanA Plasmid Associated with Vancomycin-Resistant Staphylococcus aureusAntimicrobial Agents and Chemotherapy, 2010
- Research electronic data capture (REDCap)—A metadata-driven methodology and workflow process for providing translational research informatics supportJournal of Biomedical Informatics, 2009
- Emergence of Community-Associated Methicillin-Resistant Staphylococcus aureus USA300 Genotype as a Major Cause of Health Care--Associated Blood Stream InfectionsClinical Infectious Diseases, 2006
- Utility of the Chronic Disease Score and Charlson Comorbidity Index as Comorbidity Measures for Use in Epidemiologic Studies of Antibiotic-resistant OrganismsAmerican Journal of Epidemiology, 2005
- Coexistence of Vancomycin-Resistant Enterococci and Staphylococcus aureus in the Intestinal Tracts of Hospitalized PatientsClinical Infectious Diseases, 2003
- Staphylococcus aureusInfectionsNew England Journal of Medicine, 1998
- Clinical importance of polymicrobial bacteremiaDiagnostic Microbiology and Infectious Disease, 1986